TB sandbox

Jump to navigation Jump to search

▸ Click on the following categories to expand treatment regimens.

MDR Tuberculosis

  ▸  Adults

  ▸  Children

MDR-TB Adults
Standard Regimen
Group 1: First-line oral drugs

▸ Pyrazinamide 20–30 mg/kg
OR
▸ Ethambutol 15–25 mg/kg
OR
▸ Rifabutin 5 mg/kg

PLUS
Group 2: Injectable drugs

▸ Capreomycin 15 mg/kg
OR
▸ Kanamycin 15 mg/kg
OR
▸ Amikacin 7.5-10 mg/kg
OR
▸ Streptomycin 12–18 mg/kg

PLUS
Group 3: Fluoroquinolones

▸ Levofloxacin 500-1000 mg
OR
▸ Moxifloxacin 400 mg
OR
▸ Ofloxacin 400 mg

PLUS
Group 4:Oral bacteriostatic second-line drugs

▸ Ethionamide 15-20 mg/kg
OR
▸ Protionamide 15-20 mg/kg
OR
▸ Cycloserine 10-15 mg/kg
OR
▸ Terizidone 10-20 mg/kg
OR
▸ Para-aminosalicylic acid 8-12 g/d divided q8-12h

Table adapted from WHO 2013 Treatment of Tuberculosis: Guidelines – 4th ed.[1]
MDR-TB Children
Standard Regimen
Group 1: First-line oral drugs

▸ Pyrazinamide 20-30 mg/kg (Max: 600 mg)
OR
▸ Ethambutol 15-20 mg/kg
OR
▸ Rifabutin 5 mg/kg

PLUS
Group 2: Injectable drugs

▸ Capreomycin 15-30 mg/kg (Max: 1000 mg)
OR
▸ Kanamycin 15-30 mg/kg (Max: 1000 mg)
OR
▸ Amikacin 15-22.5 mg/kg (Max: 1000 mg)
OR
▸ Streptomycin 12-18 mg/kg

PLUS
Group 3: Fluoroquinolones

▸ Levofloxacin 7.5-10 mg/kg
OR
▸ Moxifloxacin 7.5-10 mg/kg
OR
▸ Ofloxacin 15-20 mg/kg divided q12h (Max:800 mg)

PLUS
Group 4:Oral bacteriostatic second-line drugs

▸ Ethionamide 15-20 mg/kg divided q12h (Max: 1000 mg)
OR
▸ Protionamide 15-20 mg/kg divided q12h (Max: 1000 mg)
OR
▸ Cycloserine 10-20 mg/kg (Max: 1000 mg)
OR
▸ Terizidone 10-20 mg/kg (Max: 1000 mg)
OR
▸ Para-aminosalicylic acid 150 mg/kg divided q8-12h(Max: 12 000 mg)

Table adapted from WHO 2013 Treatment of tuberculosis: guidelines – 4th ed.[1] and Guidance for national tuberculosis programmes on the management of tuberculosis in children [2]


  1. ↑ 1.0 1.1 "2013 WHO Treatment of Tuberculosis: Guidelines for National Programmes (4th Edition)".
  2. ↑ "WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014" (PDF).